SuppreMol Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 50
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $230M
Latest Deal Amount

SuppreMol General Information

Description

Developer of therapeutics for the treatment of autoimmune diseases and allergic diseases. The company is focused on development of soluble Fc-gamma receptors (FcyRs), which are recombinant autologous therapeutic proteins with a specific immunoregulatory potential.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Am Klopferspitz 19a
  • Martinsried
  • 82152 Munich
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SuppreMol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-Mar-2015 $230M 000.00 00000 Completed Product Development
7. Later Stage VC (Series D) 21-May-2013 000.00 000.00 Completed Product Development
6. Grant 06-Dec-2010 00.000 000.00 Completed Product Development
5. Later Stage VC (Series C) 02-Dec-2010 000.00 000.00 Completed Product Development
4. Grant 09-Sep-2009 00.000 000.00 Completed Product Development
3. Later Stage VC (Series B) 14-Jul-2008 000.00 000.00 Completed Product Development
2. Grant 05-Mar-2007 $2.29M $4.92M Completed Product Development
1. Early Stage VC 01-May-2006 $4.92M $4.92M Completed Product Development
To view SuppreMol’s complete valuation and funding history, request access »

SuppreMol Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutics for the treatment of autoimmune diseases and allergic diseases. The company is focused on deve
Drug Discovery
Munich, Germany
50 As of 2014
000.00
0000 0000-00-00
000000&0 000.00

00000000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qu
0000 000000000
Waltham, MA
0 As of 0000
0000
00000000000 0000

00000000

, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SuppreMol Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenacy Pharmaceuticals Venture Capital-Backed Waltham, MA 0 0000 00000000000 0000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
0000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 000000 - 000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 000 Formerly VC-backed Menlo Park, CA 00 00000 00000000 00000
You’re viewing 5 of 46 competitors. Get the full list »

SuppreMol Executive Team (9)

Name Title Board Seat Contact Info
Michael Tansey Chief Development Officer
Peter Sondermann Ph.D Chief Scientific Officer & Co-Founder
Sascha Tillmanns Medical Director
Uwe Jacob Advisory Board Member & Co-Founder
Ulrich Mahr Advisory Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

SuppreMol Board Members (2)

Name Representing Role Since
Thomas Hecht Ph.D Self Chairman 000 0000
Thomas Werner Ph.D Self Advisory Board Member 000 0000
To view SuppreMol’s complete board members history, request access »

SuppreMol Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SuppreMol Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayern Kapital Venture Capital Minority 000 0000 000000 0
BioMedPartners Venture Capital Minority 000 0000 000000 0
FCP Biotech Corporation Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
MIG AG Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »